Works matching AU Shinji Atagi


Results: 68
    1

    A Randomized Phase III Study Comparing Carboplatin With Nab-Paclitaxel Versus Docetaxel for Elderly Patients With Squamous-Cell Lung Cancer: Study Protocol.

    Published in:
    2018
    By:
    • Yoshihito Kogure;
    • Hideo Saka;
    • Yuichi Takiguchi;
    • Shinji Atagi;
    • Takayasu Kurata;
    • Noriyuki Ebi;
    • Akira Inoue;
    • Kaoru Kubota;
    • Mitsuhiro Takenoyama;
    • Takashi Seto;
    • Akiko Kada;
    • Takeharu Yamanaka;
    • Masahiko Ando;
    • Nobuyuki Yamamoto;
    • Akihiko Gemma;
    • Yukito Ichinose;
    • Kogure, Yoshihito;
    • Saka, Hideo;
    • Takiguchi, Yuichi;
    • Atagi, Shinji
    Publication type:
    journal article
    2

    Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Masahiro Morimoto;
    • Kyoichi Okishio;
    • Masanori Akira;
    • Naoki Omachi;
    • Akihiro Tamiya;
    • Kazuhiro Asami;
    • Tomoya Kawaguchi;
    • Shinji Atagi;
    • Morimoto, Masahiro;
    • Okishio, Kyoichi;
    • Akira, Masanori;
    • Omachi, Naoki;
    • Tamiya, Akihiro;
    • Asami, Kazuhiro;
    • Kawaguchi, Tomoya;
    • Atagi, Shinji
    Publication type:
    journal article
    3
    4

    Randomized Phase H Trial of Amrubicin Plus Irinotecan Versus Cisplatin Plus lrinotecan in Chemo-naïve Patients With Extensive-Disease Small-Cell Lung Cancer: Results of the Japan Multinational Trial Organization (JMTO) LC 08-01.

    Published in:
    Clinical Lung Cancer, 2025, v. 26, n. 1, p. 1, doi. 10.1016/j.cllc.2024.09.004
    By:
    • Hiroshige Yoshioka;
    • Tadashi Ishida;
    • Shinji Atagi;
    • Akihiro Tamiya;
    • Takashi Nishimura;
    • Yasuo Iwamoto;
    • Masashi Kanehara;
    • Young Hak Kim;
    • Yohei Korogi;
    • Keisuke Tomii;
    • Nobuyuki Katakami;
    • Kiyoshi Komuta;
    • Masanori Nishikawa;
    • Akihiko Gemma;
    • Kenichi Yamaki;
    • Masaaki Kawahara;
    • Chisato Miyakoshi;
    • Tadashi Mio
    Publication type:
    Article
    5
    6
    7
    8
    9

    Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.

    Published in:
    2018
    By:
    • Kohei Otsubo;
    • Junji Kishimoto;
    • Hirotsugu Kenmotsu;
    • Yuji Minegishi;
    • Eiki Ichihara;
    • Akira Shiraki;
    • Terufumi Kato;
    • Shinji Atagi;
    • Hidehito Horinouchi;
    • Masahiko Ando;
    • Yasuhiro Kondoh;
    • Masahiko Kusumoto;
    • Kazuya Ichikado;
    • Nobuyuki Yamamoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto;
    • Otsubo, Kohei;
    • Kishimoto, Junji;
    • Kenmotsu, Hirotsugu;
    • Minegishi, Yuji
    Publication type:
    journal article
    10

    Early Pharmacodynamic Assessment Using <sup>18</sup>F-Fluorodeoxyglucose Positron-Emission Tomography on Molecular Targeted Therapy and Cytotoxic Chemotherapy for Clinical Outcome Prediction.

    Published in:
    Clinical Lung Cancer, 2014, v. 15, n. 3, p. 182, doi. 10.1016/j.cllc.2014.01.001
    By:
    • Masaki Kanazu;
    • Kaoru Maruyama;
    • Masahiko Ando;
    • Kazuhiro Asami;
    • Mari Ishii;
    • Kazutaka Uehira;
    • Shojiro Minomo;
    • Yoshinobu Matsuda;
    • Tomoya Kawaguchi;
    • Shinji Atagi;
    • Yoji Ogawa;
    • Yoko Kusunoki;
    • Minoru Takada;
    • Akihito Kubo
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 8, p. 1261, doi. 10.1093/jjco/hyab072
    By:
    • Sakai, Hiroshi;
    • Morise, Masahiro;
    • Kato, Terufumi;
    • Matsumoto, Shingo;
    • Sakamoto, Tomohiro;
    • Kumagai, Toru;
    • Tokito, Takaaki;
    • Atagi, Shinji;
    • Kozuki, Toshiyuki;
    • Tanaka, Hiroshi;
    • Chikamori, Kenichi;
    • Shinagawa, Naofumi;
    • Takeoka, Hiroaki;
    • Bruns, Rolf;
    • Straub, Josef;
    • Schumacher, Karl Maria;
    • Paik, Paul K
    Publication type:
    Article
    18

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    19
    20

    Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 12, p. 1, doi. 10.1007/s00262-024-03815-1
    By:
    • Sakura, Kazuma;
    • Kuroyama, Muneyoshi;
    • Shintani, Yasushi;
    • Funaki, Soichiro;
    • Atagi, Shinji;
    • Kadota, Yoshihisa;
    • Kuribayashi, Kozo;
    • Kijima, Takashi;
    • Nakano, Takashi;
    • Nakajima, Toshihiro;
    • Sasai, Masao;
    • Okumura, Meinoshin;
    • Kaneda, Yasufumi
    Publication type:
    Article
    21
    22
    23
    24
    25

    Long‐term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.

    Published in:
    Cancer Science, 2024, v. 115, n. 4, p. 1296, doi. 10.1111/cas.16107
    By:
    • Morise, Masahiro;
    • Kato, Terufumi;
    • Matsumoto, Shingo;
    • Inoue, Takako;
    • Sakamoto, Tomohiro;
    • Tokito, Takaaki;
    • Atagi, Shinji;
    • Kozuki, Toshiyuki;
    • Takeoka, Hiroaki;
    • Chikamori, Kenichi;
    • Shinagawa, Naofumi;
    • Tanaka, Hiroshi;
    • Horii, Eisuke;
    • Adrian, Svenja;
    • Bruns, Rolf;
    • Johne, Andreas;
    • Paik, Paul K.;
    • Sakai, Hiroshi
    Publication type:
    Article
    26

    Neoadjuvant nivolumab plus chemotherapy in resectable non‐small‐cell lung cancer in Japanese patients from CheckMate 816.

    Published in:
    Cancer Science, 2024, v. 115, n. 2, p. 540, doi. 10.1111/cas.16030
    By:
    • Mitsudomi, Tetsuya;
    • Ito, Hiroyuki;
    • Okada, Morihito;
    • Sugawara, Shunichi;
    • Shio, Yutaka;
    • Tomii, Keisuke;
    • Okami, Jiro;
    • Sakakura, Noriaki;
    • Kubota, Kaoru;
    • Takamochi, Kazuya;
    • Atagi, Shinji;
    • Tsuboi, Masahiro;
    • Oizumi, Satoshi;
    • Ikeda, Norihiko;
    • Ohde, Yasuhisa;
    • Ntambwe, Ives;
    • Mahmood, Javed;
    • Cai, Junliang;
    • Tanaka, Fumihiro
    Publication type:
    Article
    27

    Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 5, p. 1000, doi. 10.1111/cas.13225
    By:
    • Hida, Toyoaki;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Ohe, Yuichiro;
    • Nokihara, Hiroshi;
    • Sakai, Hiroshi;
    • Satouchi, Miyako;
    • Nakagawa, Kazuhiko;
    • Takenoyama, Mitsuhiro;
    • Isobe, Hiroshi;
    • Fujita, Shiro;
    • Tanaka, Hiroshi;
    • Minato, Koichi;
    • Takahashi, Toshiaki;
    • Maemondo, Makoto;
    • Takeda, Koji;
    • Saka, Hideo;
    • Goto, Koichi;
    • Atagi, Shinji;
    • Hirashima, Tomonori
    Publication type:
    Article
    28
    29
    30
    31

    Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18442-4
    By:
    • Wang, Rong;
    • Yamada, Tadaaki;
    • Kita, Kenji;
    • Taniguchi, Hirokazu;
    • Arai, Sachiko;
    • Fukuda, Koji;
    • Terashima, Minoru;
    • Ishimura, Akihiko;
    • Nishiyama, Akihiro;
    • Tanimoto, Azusa;
    • Takeuchi, Shinji;
    • Ohtsubo, Koshiro;
    • Yamashita, Kaname;
    • Yamano, Tomoyoshi;
    • Yoshimura, Akihiro;
    • Takayama, Koichi;
    • Kaira, Kyoichi;
    • Taniguchi, Yoshihiko;
    • Atagi, Shinji;
    • Uehara, Hisanori
    Publication type:
    Article
    32
    33

    Standard versus low‐dose nab‐paclitaxel in previously treated patients with advanced non‐small cell lung cancer: A randomized phase II trial (JMTO LC14‐01).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 8, p. 9133, doi. 10.1002/cam4.5652
    By:
    • Takeuchi, Susumu;
    • Kubota, Kaoru;
    • Sugawara, Shunichi;
    • Teramukai, Satoshi;
    • Noro, Rintaro;
    • Fujikawa, Kei;
    • Hirose, Takashi;
    • Atagi, Shinji;
    • Minami, Seigo;
    • Iida, Shinichiro;
    • Kuraishi, Hiroshi;
    • Aiba, Tomoiki;
    • Minegishi, Yuji;
    • Matsumoto, Masaru;
    • Seike, Masahiro;
    • Gemma, Akihiko;
    • Kawahara, Masaaki
    Publication type:
    Article
    34
    35
    36

    Three‐year follow‐up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non‐small cell lung cancer: Pooled analysis of ONO‐4538‐05 and ONO‐4538‐06 studies.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 11, p. 5183, doi. 10.1002/cam4.2411
    By:
    • Horinouchi, Hidehito;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Saka, Hideo;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Sumiyoshi, Naoki
    Publication type:
    Article
    37
    38

    Patient-reported outcomes in RELAY, a phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small-cell lung cancer.

    Published in:
    Current Medical Research & Opinion, 2020, v. 36, n. 10, p. 1667, doi. 10.1080/03007995.2020.1808781
    By:
    • Yoh, Kiyotaka;
    • Atagi, Shinji;
    • Reck, Martin;
    • Garon, Edward B.;
    • Ponce Aix, Santiago;
    • Moro-Sibilot, Denis;
    • Winfree, Katherine B.;
    • Frimodt-Moller, Bente;
    • Zimmermann, Annamaria;
    • Visseren-Grul, Carla;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    39

    Standard Thoracic Radiotherapy With or Without Concurrent Daily Low-dose Carboplatin in Elderly Patients with Locally Advanced Non-small Cell Lung Cancer: a Phase III Trial of the Japan Clinical Oncology Group (JCOG9812).

    Published in:
    Japanese Journal of Clinical Oncology, 2005, v. 35, n. 4, p. 195, doi. 10.1093/jjco/hyi060
    By:
    • Atagi, Shinji;
    • Kawahara, Masaaki;
    • Tamura, Tomohide;
    • Noda, Kazumasa;
    • Watanabe, Koshiro;
    • Yokoyama, Akira;
    • Sugiura, Takahiko;
    • Senba, Hiroshi;
    • Ishikura, Satoshi;
    • Ikeda, Hiroshi;
    • Ishizuka, Naoki;
    • Saijo, Nagahiro
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46

    Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904
    By:
    • Shimokawa, Mototsugu;
    • Kanazu, Masaki;
    • Saito, Ryusei;
    • Mori, Masahide;
    • Tamura, Atsuhisa;
    • Okano, Yoshio;
    • Fujita, Yuka;
    • Endo, Takeo;
    • Motegi, Mitsuru;
    • Takata, Shohei;
    • Kita, Toshiyuki;
    • Sukoh, Noriaki;
    • Mizuki, Fumitaka;
    • Takenoyama, Mitsuhiro;
    • Atagi, Shinji
    Publication type:
    Article
    47

    A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 12, p. 1827, doi. 10.1111/1759-7714.14465
    By:
    • Asami, Kazuhiro;
    • Ando, Masahiko;
    • Nishimura, Takashi;
    • Yokoi, Takashi;
    • Tamura, Atsuhisa;
    • Minato, Koichi;
    • Mori, Masahide;
    • Ogushi, Fumitaka;
    • Yamamoto, Akiyoshi;
    • Yoshioka, Hiroshige;
    • Kawahara, Masaaki;
    • Atagi, Shinji
    Publication type:
    Article
    48
    49
    50